Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Feb;70(2):749-61.
doi: 10.1128/IAI.70.2.749-761.2002.

Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae

Affiliations

Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae

Abdul Q Khan et al. Infect Immun. 2002 Feb.

Abstract

Proinflammatory cytokines play a critical role in innate host defense against extracellular bacteria. However, little is known regarding the effects of these cytokines on the adaptive humoral response. Mice injected with a neutralizing anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody (MAb) at the time of primary immunization with intact Streptococcus pneumoniae (strain R36A) showed a substantial reduction in both the primary immunoglobulin G (IgG) response specific for the cell wall protein, pneumococcal surface protein A (PspA), as well as in the development of PspA-specific memory. In contrast, anti-TNF-alpha MAb injected only at the time of secondary immunization with R36A failed to alter the boosted anti-PspA response. TNF-alpha was required only within the first 48 to 72 h after primary immunization with R36A and was induced both by non-B and non-T cells and by lymphoid cells, within 2 to 6 h after immunization, with levels returning to normal by 24 h. Thus, the early innate release of TNF-alpha was critical for optimal stimulation of the subsequent adaptive humoral response to R36A. Additional proinflammatory (interleukin 1 [IL-1], IL-6, IL-12, and gamma interferon [IFN-gamma]) as well as anti-inflammatory (IL-4 and IL-10) cytokines were also transiently induced. Mice genetically deficient in IL-6, IFN-gamma, or IL-12 also showed a reduced IgG anti-PspA response of all IgG isotypes. In contrast, IL-4(-/-) and IL-10(-/-) mice immunized with R36A showed a significant elevation in the IgG anti-PspA response, except that there was decreased IgG1 in IL-4(-/-) mice. In this regard, a marked enhancement in the induction of proinflammatory cytokines was observed in the absence of IL-10, relative to controls. Ig isotype titers specific for the phosphorycholine determinant of C-polysaccharide were similarly regulated, but to a much more modest degree. These data suggest that proinflammatory and anti-inflammatory cytokines differentially regulate an in vivo protein- and polysaccharide-specific Ig response to an extracellular bacteria.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Endogenous TNF-α is a key positive regulator of the in vivo anti-PspA, anti-PsaA and, to a lesser extent, anti-PC response to R36A. Mice were injected i.p. with 0.5 mg of anti-TNF-α MAb (XT22) or the same amount of control rat IgG1 MAb (GL113) or saline. Twenty-four hours later mice were injected i.p. with R36A (2 × 108 CFU/mouse). Sera were collected 1 week after primary immunization with R36A for determination of anti-PC titers and 2 weeks after immunization for determination of anti-PspA and anti-PsaA titers by ELISA. Values represent arithmetic means ± SEM of eight mice per group. *, P < 0.05. Data are representative of three similar experiments.
FIG. 2.
FIG. 2.
TNF-α is required for an optimal primary anti-PspA response and the development of PspA-specific memory, but not for elicitation of a secondary response to R36A. (A) Mice were injected i.p. with 0.5 mg of anti-TNF-α MAb or control MAb. Twenty-four hours later mice were injected i.p. with R36A (2 × 108 CFU/mouse). Six weeks after R36A immunization, mice were boosted with R36A alone (2 × 108 CFU/mouse). Sera were collected 2 weeks after primary immunization with R36A (primary) and 1 week after boosting with R36A (secondary) for determination of anti-PspA titers. Values represent arithmetic means ± SEM of eight mice per group. *, P < 0.05. (B) Mice were injected i.p. with R36A alone (2 × 108 CFU/mouse). Two weeks later primed mice were injected i.p. with 0.5 mg of anti-TNF-α MAb and/or 0.5 mg of control MAb, followed 24 h later by boosting with R36A (108 CFU/mouse). Values represent the arithmetic means ± SEM of eight mice per group. *, P < 0.05. One experiment was performed.
FIG. 3.
FIG. 3.
TNF-α is required within the first 48 to 72 h after R36A immunization for induction of an anti-PspA response. Mice were immunized i.p. with R36A (108 CFU/mouse), and then distinct sets of mice were injected i.p. with 0.5 mg of either anti-TNF-α MAb or control MAb at different times (days 0 to 5). Sera were collected 2 weeks after primary immunization with R36A for the determination of anti-PspA titers. Values represent the arithmetic means ± SEM of five mice per group. *, P < 0.05. Data are representative of two similar experiments.
FIG. 4.
FIG. 4.
R36A induces a mixed cytokine response in vivo within 2 to 6 h. Real-time RT-PCR analysis of cytokine mRNA expression was performed on freshly harvested splenic non-B, -non-T cells and B + T cells by magnetic sorting at different time points after immunization with R36A (2 × 108 CFU/mouse). Relative levels of cytokine-specific mRNA were standardized based on rRNA levels. Cytokine-specific mRNA levels in sorted spleen cells from unimmunized mice were arbitrarily assigned a value of 1. Data are representative of two similar experiments.
FIG. 5.
FIG. 5.
Proinflammatory cytokines stimulate the humoral response to R36A. IL-6−/−, IL-12−/−, IFN-γ−/−, and control mice were immunized i.p with R36A (2 × 108 CFU/mouse). Sera were collected on day 7 (primary anti-PC), day 14 (primary anti-PspA), and day 21 (secondary anti-PspA) after immunization. Values are expressed as the arithmetic means ± SEM of eight mice per group. *, P < 0.05. Data are representative of two similar experiments.
FIG. 6.
FIG. 6.
Role of R36A dose in induction of anti-PspA and anti-PC responses in IL-12−/− mice. IL-12−/− and control mice (five per group) were immunized i.p. with three different doses of R36A (10 × 106, 50 × 106, and 200 × 106 CFU/mouse). Sera were collected on day 7 (anti-PC) and day 14 (anti-PspA) after immunization. Values represent the arithmetic means ± SEM. *, P < 0.05. One experiment was performed.
FIG. 7.
FIG. 7.
Role of anti-inflammatory cytokines in the humoral response to R36A . IL-4−/−, IL-10−/−, and control mice were immunized i.p. with R36A (2 × 108 CFU/mouse). Sera were collected on day 7 (primary anti-PC), day 14 (primary anti-PspA), and day 21 after boosting with R36A (secondary anti-PspA). Values represent the arithmetic means ± SEM of seven mice per group. *, P < 0.05. Data are representative of two similar experiments.
FIG. 8.
FIG. 8.
Role of cytokines in Ig isotype response to S. pneumoniae.
FIG. 9.
FIG. 9.
Endogenous IL-10 suppresses proinflammatory cytokine induction in response to R36A. Spleen cells from wild-type and IL-10−/− mice were cultured at 107 cells/ml in the presence of 2 × 108 CFU/ml of R36A for 24 h. In addition, wild-type spleen cells were cultured with anti-IL-10 MAb or control MAb (10 μg/ml). Concentrations of IL-6, IL-10, IL-12, IFN-γ, and TNF-α in the culture supernatants were measured by ELISA. The results are representative of two independent experiments and are shown as means ± SEM of triplicate wells. *, P < 0.05 in Student's t test.

References

    1. Abrams, J. S., M. G. Roncarolo, H. Yssel. U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies for anticytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5-24. - PubMed
    1. Akira, S. 2000. Toll-like receptors: lessons from knockout mice. Biochem. Soc. Trans. 28:551-556. - PubMed
    1. AlonsoDeVelasco, E., A. F. M. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59:591-603. - PMC - PubMed
    1. Arase, H., N. Arase, K.-I. Nakagawa, R. A. Good, and K. Onoe. 1993. NK1.1+ CD4+ CD8− thymocytes with specific lymphokine secretion. Eur. J. Immunol. 23:307-310. - PubMed
    1. Avery, O. T., C. M. MacLeod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 79:137-146. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources